跳转至内容
Merck
CN

20832-U

Supelco

ORBO 402 Tenax® TA 经过特殊处理(35/60),100/50mg

W,W,W separators, O.D. × L 8 mm × 100 mm, pkg of 50 ea

别名:

ORBO Tenax® TA

登录查看公司和协议定价

关于此项目

UNSPSC代码:
12190000
NACRES:
NB.24
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

物料

W,W,W separators

质量水平

Agency

NIOSH 2507,2545,7905
OSHA 43

产品线

ORBO

组成

Bed A, 100 mg
Bed B, 50 mg

包装

pkg of 50 ea

制造商/商品名称

ORBO 402

技术

active air sampling: suitable

外径 × 长度

8 mm × 100 mm

基质

Tenax TA (specially treated)

粒径

35-60 mesh

应用

air monitoring
environmental
industrial hygiene

正在寻找类似产品? 访问 产品对比指南

一般描述

ORBO 402 Tenax® TA吸附管(特别处理,35/60,100/50 mg)用于气体或蒸汽采样。它是装填双层填充床的玻璃管,双层填充床采用相同的选择性吸附剂,中间由玻璃棉或泡沫隔开。双层设计使较少一层填充床可作为后备,捕获因过载而穿透前一层填充床的样品。

适用气相色谱-质谱(GC-MS)仪器,常用于呼吸分析。

应用

ORBO 402 Tenax® TA吸附管(特别处理,35/60,100/50 mg)可作为吸附剂采集空气样品,用于GC/MS法测定环境中的微量苯。

法律信息

ORBO is a trademark of Sigma-Aldrich Co. LLC
Tenax is a registered trademark of Buchem B.V.

象形图

Exclamation mark

警示用语:

Warning

危险声明

危险分类

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

靶器官

Respiratory system

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

dust mask type N95 (US), Eyeshields, Gloves


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Determination of benzene at trace levels in air by a novel method based on solid-phase microextraction gas chromatography/mass spectrometry.
Alessandro S, et al.
Rapid Communications in Mass Spectrometry, 15, 2404-2408 (2001)
H Stalsberg et al.
Virchows Archiv. A, Pathological anatomy and histopathology, 414(5), 415-422 (1989-01-01)
The autopsies of 12 victims from two snow avalanches in North-Norway are reported. Supportive evidence from non-autopsied and surviving victims is included. Consistent autopsy findings were prominent lung oedema, moderate cerebral oedema, extreme contraction of the left ventricle, petechiae in
Anne Ørbo et al.
The Journal of steroid biochemistry and molecular biology, 113(1-2), 139-149 (2009-01-14)
Patients with endometrial hyperplasia representing preliminary stages of endometrial cancer have shown to respond to therapy in 100% of the cases when treated with levonorgestrel-impregnated intrauterine device. Anti-proliferative effect has also been reported after application of an anti-progestin impregnated intrauterine
Anne Beate Vereide et al.
Gynecologic oncology, 97(3), 740-750 (2005-05-12)
The aim of the study was to investigate apoptosis as a growth regulatory mechanism of gestagen in endometrial precancers and to compare differences in the apoptotic cascade after high and low dose gestagen regimens. Pre- and post-treatment paraffin-embedded endometrial hyperplasia
Anne Ørbo et al.
Anticancer research, 35(12), 6401-6409 (2015-12-08)
To investigate if a levonorgestrel-impregnated intrauterine system (LNG-IUS) was more efficient compared to oral progestin in the clearance of the paired box 2 gene (PAX2) - and phosphatase and tensin homolog (PTEN)-null endometrial glands and assess the significance of PAX2-

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持